InstaDent - 2026 Company Profile, Team & Financials

About InstaDent

InstaDent is a publicly listed company based in New Delhi (India) founded in 2021. It provides an online procurement platform for dental supplies and equipment. It operates on a B2B model. The company has 94 employees. Its Indian entity Vasa Denticity Limited reported revenue of ₹251 Cr. Its focus areas include Medical Supplies, Dental Products and Online Procurement. Its competitors include DentalKart, CureMint, Prevest DenPro, DD and Unicorn DenMart and 4 more; 5 of its 9 listed competitors have raised funding.

Company details

InstaDent provides an online procurement platform for dental supplies and equipment through providing healthcare solutions, medical supplies, dental products, and online procurement. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Headquarters New Delhi, India
Employees 94
Stage Public
Sectors
Healthcare
Website instadent.in
Social X Facebook
Legal Name Vasa Denticity Limited
Date of Incorporation 29 Aug, 2016
Jurisdiction New Delhi, Delhi, India

Operational Areas

Healthcare → Medical Equipment & Supplies

Key Metrics

Market Cap
₹763 Cr
DENTALKART-SM · NSE
Share Price
₹421.30
-4.25% today
Revenue
₹279 Cr
FY 2025-26 · +11.8% YoY
EBITDA
₹10.91 Cr
Margin 3.9%
Net Profit
₹10.23 Cr
FY 2025-26 · -37.5% YoY
P/E (TTM)
65.8x
P/B 4.4x
Employee Count
94

Associated legal entities of InstaDent

InstaDent is associated with 2 registered companies on The Company Check; the primary company is Vasa Denticity Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2025)	Employees	Directors	Company page
Vasa Denticity Limited Listed CIN L74999DL2016PLC305052	Active	29 Aug 2016	New Delhi, Delhi	₹251 Cr	94	8	View details
Vasa Denticity Limited CIN U74999DL2016PLC305052	–	29 Aug 2016	New Delhi, Delhi, India	–	–	–	View details

Board of directors of Vasa Denticity Limited (InstaDent)

Vasa Denticity Limited is the primary company behind InstaDent. The board of Vasa Denticity Limited currently have 6 directors; the longest-serving is Sandeep Aggarwal, appointed in 2016. 7 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Sandeep Aggarwal DIN 07484533	Whole-time director	29 Aug 2016	10 yrs 1 mo	Vasa Denticity Limited
Vikas Agarwal DIN 07487686	Managing Director	29 Aug 2016	10 yrs 1 mo	Vasa Denticity Limited
Akanksha Aggarwal DIN 10056201	Director	01 Mar 2023	3 yrs 7 mo	Vasa Denticity Limited
Ravi Jagetiya DIN 08734797	Director	17 Mar 2023	3 yrs 7 mo	Vasa Denticity Limited
Varun Chugh DIN 10053612	Director	17 Mar 2023	3 yrs 7 mo	Vasa Denticity Limited
Rohan Kaushikbhai Bhatt DIN 10799309	Director	14 Nov 2024	1 yr 11 mo	Vasa Denticity Limited

IPO & Listings of InstaDent

InstaDent is a publicly listed company on the NSE with ticker symbol DENTALKART in India, operating in the E-Commerce/App based Aggregator sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Listed onNSE: DENTALKART
Listed entityVasa Denticity Limited
Exchange sectorE-Commerce/App based Aggregator

Financials of InstaDent

Exchange-reported figures of Vasa Denticity Limited, the listed company behind InstaDent (NSE: DENTALKART-SM).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹279 Cr

+11.8% YoY

EBITDA

₹10.91 Cr

-52.6% YoY

Profit After Tax

₹10.23 Cr

-37.5% YoY

Net Worth

₹174 Cr

+31.3% YoY

Total Assets

₹177 Cr

+31.1% YoY

Total Debt

₹0.12 Cr

0.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24
Income statement
Revenue	279	249	172
Revenue growth	+11.8%	+45.1%	-
EBITDA	10.91	23.03	19.07
EBITDA margin	+3.9%	+9.2%	+11.1%
Profit before tax	13.18	23.13	19.41
Net profit	10.23	16.36	14.83
Net profit margin	+3.7%	+6.6%	+8.6%
EPS (₹)	5.99	10.21	37.65
Balance sheet
Total assets	177	135	69.39
Net worth	174	133	68.35
Total debt	0.12	0.12	0.08
Cash & bank	4.80	4.40	13.58
Net working capital	104	67.32	52.77
Cash flow
Cash from operations	(25.09)	(3.55)	(11.45)
Cash from investing	(4.48)	(42.68)	(22.36)
Cash from financing	29.90	46.81	36.42

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	83.14	73.26	72.16	72.94	60.51	73.02	62.83	59.39
Revenue growth (YoY)	+37.4%	+0.3%	+14.9%	+22.8%	+13.0%	-	-	-
Other income	0.92	2.04	0.88	0.63	0.96	0.19	0.45	0.97
EBITDA	5.07	0.29	1.75	5.84	3.04	6.39	5.52	6.39
EBITDA margin	+6.1%	+0.4%	+2.4%	+8.0%	+5.0%	+8.8%	+8.8%	+10.8%
Depreciation	0.81	0.70	0.65	0.43	0.33	0.59	0.50	0.28
Interest	0.01	0.02	0.10	0.00	0.00	0.01	0.00	0.00
Profit before tax	5.17	1.61	1.88	6.04	3.67	5.98	5.47	7.08
Tax	1.12	0.35	0.54	1.40	1.00	1.84	1.49	1.73
Net profit	4.05	1.26	1.34	4.64	2.67	4.14	3.98	5.35
EPS (₹)	2.36	0.77	0.79	2.83	1.65	2.54	2.45	3.35

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	277	249	172	123	76.92	40.07	30.42
Revenue growth	+11.0%	+45.0%	+39.4%	+60.3%	+92.0%	+31.7%	-
EBITDA	11.28	23.17	19.07	10.41	5.58	0.50	0.23
EBITDA margin	+4.1%	+9.3%	+11.1%	+8.4%	+7.3%	+1.3%	+0.8%
Profit before tax	14.03	23.30	19.41	9.95	5.01	0.46	0.09
Net profit	10.78	16.47	14.83	7.60	4.99	0.34	0.09
Net profit margin	+3.9%	+6.6%	+8.6%	+6.2%	+6.5%	+0.9%	+0.3%
EPS (₹)	6.30	10.28	9.41	5.92	249.80	16.29	4.72
Balance sheet
Total assets	176	134	69.40	17.78	9.45	2.85	1.14
Net worth	175	133	68.35	15.83	5.73	0.60	0.27
Total debt	0.00	0.00	0.08	1.02	3.26	1.97	0.65
Cash & bank	3.44	4.12	13.52	1.48	1.56	1.14	0.50
Net working capital	104	67.06	52.70	14.59	7.50	2.25	0.71
Cash flow
Cash from operations	(26.55)	(4.57)	(11.41)	1.74	0.23	(0.46)	0.80
Cash from investing	(4.10)	(41.77)	(22.46)	(1.02)	(0.43)	(1.29)	(0.41)
Cash from financing	29.90	46.70	36.42	(0.13)	0.81	1.26	(0.06)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	82.17	72.41	71.47	72.72	60.02	72.80	62.83	59.39
Revenue growth (YoY)	+36.9%	-0.5%	+13.8%	+22.4%	+12.1%	-	-	-
Other income	0.94	2.08	0.93	0.66	0.98	0.19	0.45	0.97
Total expenses	77.09	72.19	69.64	66.66	56.86	66.28	57.31	53.00
EBITDA	5.08	0.22	1.83	6.06	3.16	6.52	5.52	6.39
EBITDA margin	+6.2%	+0.3%	+2.6%	+8.3%	+5.3%	+9.0%	+8.8%	+10.8%
Depreciation	0.70	0.61	0.56	0.34	0.27	0.56	0.50	0.28
Interest	0.01	0.02	0.10	0.00	0.00	0.00	0.00	0.00
Profit before tax	5.31	1.67	2.10	6.38	3.87	6.15	5.47	7.08
Tax	1.11	0.32	0.54	1.40	1.00	1.83	1.49	1.73

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 22 Oct 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	83.14	73.26	72.16	72.94	60.51	73.02	62.83	59.39
Revenue growth (YoY)	+37.4%	+0.3%	+14.9%	+22.8%	+13.0%	-	-	-
Other income	0.92	2.04	0.88	0.63	0.96	0.19	0.45	0.97
EBITDA	5.07	0.29	1.75	5.84	3.04	6.39	5.52	6.39
EBITDA margin	+6.1%	+0.4%	+2.4%	+8.0%	+5.0%	+8.8%	+8.8%	+10.8%
Depreciation	0.81	0.70	0.65	0.43	0.33	0.59	0.50	0.28
Interest	0.01	0.02	0.10	0.00	0.00	0.01	0.00	0.00
Profit before tax	5.17	1.61	1.88	6.04	3.67	5.98	5.47	7.08
Tax	1.12	0.35	0.54	1.40	1.00	1.84	1.49	1.73
Net profit	4.05	1.26	1.34	4.64	2.67	4.14	3.98	5.35
EPS (₹)	2.36	0.77	0.79	2.83	1.65	2.54	2.45	3.35

Particulars	FY 2025-26	FY 2024-25	FY 2023-24
Revenue	279	249	172
Revenue growth	+11.8%	+45.1%	-
Other income	4.51	1.94	1.43
Total expenses	268	226	153
Employee cost	0.00	13.83	8.22
EBITDA	10.91	23.03	19.07
EBITDA margin	+3.9%	+9.2%	+11.1%
Depreciation	2.12	1.73	1.00
Interest	0.12	0.11	0.09
Profit before tax	13.18	23.13	19.41
Tax	3.28	6.22	4.33
Net profit	10.23	16.36	14.83
Net profit margin	+3.7%	+6.6%	+8.6%
EPS (₹)	5.99	10.21	37.65

Particulars	FY 2025-26	FY 2024-25	FY 2023-24
Equity & liabilities
Share capital	17.34	16.62	16.02
Reserves & surplus	154	103	52.33
Shareholders' funds (net worth)	174	133	68.35
Minority interest	1.40	1.13	0.00
Secured loans	0.00	0.00	0.00
Unsecured loans	0.12	0.12	0.08
Total debt	0.12	0.12	0.08
Total liabilities	177	135	69.39
Assets
Gross block	31.06	19.39	3.95
Net block	25.35	15.79	1.91
Capital work in progress	0.64	6.41	1.27
Investments	42.47	42.03	12.18
Inventories	81.16	53.71	33.97
Sundry debtors	12.05	13.88	11.27
Cash & bank balances	4.80	4.40	13.58
Loans & advances	26.91	11.84	10.30
Total current assets	125	83.83	69.12
Total current liabilities	20.78	16.51	16.35
Net working capital	104	67.32	52.77
Total assets	177	135	69.39

Particulars	FY 2025-26	FY 2024-25	FY 2023-24
Opening cash	4.40	3.83	1.22
Net cash from operating activities	(25.09)	(3.55)	(11.45)
Net cash from investing activities	(4.48)	(42.68)	(22.36)
Net cash from financing activities	29.90	46.81	36.42
Net change in cash	0.33	0.57	2.61
Closing cash	4.80	4.40	13.58

Particulars	FY 2025-26	FY 2024-25	FY 2023-24
Growth
Sales growth	+11.8%	+45.1%	-
EBITDA growth	-52.6%	+20.8%	-
PBT growth	-43.0%	+9997.0%	+9997.0%
Net income growth	-37.5%	+10.3%	-
Profitability & leverage
Net income margin	+3.6%	+6.8%	+8.8%
Return on capital employed	-	+22.9%	+112.4%
Return on net worth	-	+16.8%	+88.3%
Debt / equity	-	0.00	0.00
Long-term debt / equity	-	0.00	0.00
Interest cover	1.37	0.52	0.50
Efficiency & per share
Fixed asset turnover	-	21.37	174.06
Inventory turnover	-	5.69	20.24
Debtors turnover	-	19.83	61.00
EPS (₹)	5.99	10.21	37.65
Dividend per share (₹)	0.00	0.00	0.00
Book value per share (₹)	0.00	72.20	42.67

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	82.17	72.41	71.47	72.72	60.02	72.80	62.83	59.39
Revenue growth (YoY)	+36.9%	-0.5%	+13.8%	+22.4%	+12.1%	-	-	-
Other income	0.94	2.08	0.93	0.66	0.98	0.19	0.45	0.97
Total expenses	77.09	72.19	69.64	66.66	56.86	66.28	57.31	53.00
EBITDA	5.08	0.22	1.83	6.06	3.16	6.52	5.52	6.39
EBITDA margin	+6.2%	+0.3%	+2.6%	+8.3%	+5.3%	+9.0%	+8.8%	+10.8%
Depreciation	0.70	0.61	0.56	0.34	0.27	0.56	0.50	0.28
Interest	0.01	0.02	0.10	0.00	0.00	0.00	0.00	0.00
Profit before tax	5.31	1.67	2.10	6.38	3.87	6.15	5.47	7.08
Tax	1.11	0.32	0.54	1.40	1.00	1.83	1.49	1.73

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	277	249	172	123	76.92	40.07	30.42
Revenue growth	+11.0%	+45.0%	+39.4%	+60.3%	+92.0%	+31.7%	-
Other income	4.65	1.94	1.43	0.48	0.22	0.11	0.03
Total expenses	265	226	153	113	71.34	39.57	30.19
Employee cost	0.00	13.67	8.22	7.11	4.13	1.66	2.39
EBITDA	11.28	23.17	19.07	10.41	5.58	0.50	0.23
EBITDA margin	+4.1%	+9.3%	+11.1%	+8.4%	+7.3%	+1.3%	+0.8%
Depreciation	1.78	1.71	1.00	0.54	0.31	0.09	0.08
Interest	0.12	0.10	0.09	0.40	0.48	0.06	0.09
Profit before tax	14.03	23.30	19.41	9.95	5.01	0.46	0.09
Tax	3.25	6.21	4.33	2.35	0.02	0.12	0.00
Net profit	10.78	16.47	14.83	7.60	4.99	0.34	0.09
Net profit margin	+3.9%	+6.6%	+8.6%	+6.2%	+6.5%	+0.9%	+0.3%
EPS (₹)	6.30	10.28	9.41	5.92	249.80	16.29	4.72

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	17.34	16.62	16.02	12.84	0.20	0.20	0.20
Reserves & surplus	155	104	52.33	2.99	5.53	0.40	0.07
Shareholders' funds (net worth)	175	133	68.35	15.83	5.73	0.60	0.27
Secured loans	0.00	0.00	0.08	0.83	1.28	1.97	0.60
Unsecured loans	0.00	0.00	0.00	0.19	1.98	0.00	0.05
Total debt	0.00	0.00	0.08	1.02	3.26	1.97	0.65
Total liabilities	176	134	69.40	17.78	9.45	2.85	1.14
Assets
Gross block	27.31	18.53	3.89	3.04	1.27	0.65	0.45
Net block	21.96	14.96	1.87	2.02	0.79	0.47	0.36
Capital work in progress	0.63	4.53	1.27	0.00	0.00	0.00	0.00
Investments	45.02	43.94	12.28	0.00	0.00	0.00	0.00
Inventories	80.60	53.60	33.97	17.78	9.93	2.78	2.29
Sundry debtors	11.49	13.65	11.27	0.98	1.36	0.76	0.80
Cash & bank balances	3.44	4.12	13.52	1.48	1.56	1.14	0.50
Loans & advances	28.99	11.96	10.29	4.31	4.30	1.64	0.81
Total current assets	125	83.33	69.05	24.55	17.15	6.32	4.40
Total current liabilities	20.38	16.27	16.35	9.96	9.65	4.07	3.69
Net working capital	104	67.06	52.70	14.59	7.50	2.25	0.71
Total assets	176	134	69.40	17.78	9.45	2.85	1.14

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	4.12	3.77	1.22	0.63	0.01	0.50	0.18
Net cash from operating activities	(26.55)	(4.57)	(11.41)	1.74	0.23	(0.46)	0.80
Net cash from investing activities	(4.10)	(41.77)	(22.46)	(1.02)	(0.43)	(1.29)	(0.41)
Net cash from financing activities	29.90	46.70	36.42	(0.13)	0.81	1.26	(0.06)
Net change in cash	(0.75)	0.36	2.55	0.59	0.61	(0.48)	0.32
Closing cash	3.37	4.12	13.52	1.48	1.56	1.14	0.50

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+11.0%	+45.0%	+39.4%	+60.3%	+92.0%	+31.7%	-
EBITDA growth	-51.3%	+21.5%	+83.2%	+86.6%	+1016.0%	+117.4%	-
PBT growth	-39.8%	+20.0%	+95.1%	+98.6%	+989.1%	+411.1%	+9997.0%
Net income growth	-34.6%	+11.1%	+95.1%	+52.3%	+1367.7%	+277.8%	-
Revenue CAGR (3Y)	+30.9%	+48.0%	+62.5%	+59.5%	-	-	-
EBITDA CAGR (3Y)	+2.7%	+60.7%	+236.6%	+256.4%	-	-	-
Profitability & leverage
Net income margin	+3.9%	+6.9%	+8.8%	+6.2%	+6.5%	+0.9%	+0.3%
Return on capital employed	-	+23.1%	+44.7%	+76.0%	+89.4%	+25.6%	+15.8%
Return on net worth	-	+17.0%	+35.8%	+70.5%	+158.0%	+75.9%	+33.3%
Debt / equity	-	0.00	0.01	0.20	0.83	3.02	2.40
Long-term debt / equity	-	0.00	0.00	0.08	0.23	0.01	0.01
Interest cover	1.26	0.47	0.50	4.05	9.11	14.63	60.00
Efficiency & per share
Fixed asset turnover	-	22.23	49.60	57.23	80.13	72.85	67.60
Inventory turnover	-	5.69	6.64	8.90	12.10	15.81	13.28
Debtors turnover	-	20.00	28.06	105.40	72.57	51.37	38.03
EPS (₹)	6.30	10.28	9.41	5.92	249.80	16.29	4.72
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	72.28	42.67	12.32	286.33	29.89	13.60

Competitors of InstaDent

InstaDent has 9 listed competitors in our database, 5 of them funded. They include DentalKart, CureMint, Prevest DenPro, DD and Unicorn DenMart, among others.

Company Name	Domain	Founded	HQ Location	Total funding	Employees	Description
DentalKart	dentalkart.com	2016	Delhi, India	–	204	Online marketpalce offering dental supplies for healthcare professionals and individuals
CureMint	curemint.io	2017	Los Angeles, United States	$5.8M	9	Cloud-based procurement platform for dental supplies and resources is provided.
Prevest DenPro	prevestdenpro.com	1999	Jammu, India	–	126	Dental materials manufacturer
DD	ddgroup.com	1971	Witham, United Kingdom	–	410	Dental products are supplied via an online platform by DD.
Unicorn DenMart	unicorndenmart.com	2008	Delhi, India	$394,600	144	Dental equipment and supplies are offered online by Unicorn DenMart.
DentaCarts	dentacarts.com	2016	Cairo, Egypt	$450,000	–	Dental products are distributed online to Egyptian clinics and dentists.
PinkBlue	pinkblue.in	2014	Bengaluru, India	$2.39M	1	Dental supplies are provided online by PinkBlue for healthcare institutions.
Dentira	dentira.com	2018	San Francisco, United States	–	33	Online dental product procurement platform for healthcare professionals
Supply Clinic	supplyclinic.com	2014	Chicago, United States	$397,996	38	Dental supplies marketplace operated online for clinicians and vendors.

Premium access

Detailed competitors of InstaDent

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

Full competitor set
Operating metrics
Benchmarks
Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Medical Equipment & Supplies

10 companies that operate in the same segment as InstaDent (Medical Equipment & Supplies), ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Brainlab	Software and integrated solutions for surgical and radiotherapy applications	1989	Munchen, Bayern, Germany	USD 5.38 M	USD 1.18 M	18
PROCEPT BioRobotics	Robotic waterjet system for prostate tissue removal is developed.	2009	Redwood City, California, United States	USD 348.84 M	USD 308.05 M	756
CMR Surgical	Collaborative surgical robotic systems are provided for hospital procedures.	2014	Cambridge, Cambridgeshire, United Kingdom	USD 1.68 B	USD 48.75 M	680
Auris Health	Robotic microsurgical systems for endoscopy are developed.	2007	Redwood City, California, United States	USD 733.62 M	–	91
Augmedics	Augmented reality systems for guiding surgical procedures are developed.	2014	Yokneam Illit, North District, Israel	USD 142.6 M	–	–
Olympus	Manufacturer of imaging and surgical products	1919	Tokyo, Tokyo, Japan	–	USD 6.49 B	35,933
West Pharmaceutical Services	Injectable packaging, containment, and delivery solutions are manufactured.	1923	Exton, Pennsylvania, United States	–	USD 3.07 B	10,600
410 Medical	Rapid infusion systems are provided for critically ill patients.	2012	Durham, North Carolina, United States	USD 77.98 M	–	–
Blue Ocean Robotics	Mobile robots are manufactured for industries including healthcare and agriculture.	2013	Odense, Denmark	USD 81.44 M	–	303
Proprio	Visualization systems for surgical procedures are developed using machine learning.	2016	Seattle, Washington, United States	USD 74.25 M	–	52

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Instadent

Ashish Kacholia raises stake in this multibagger stock after 200% rally. Do you own?

Mint • 2 months ago

Vasa Denticity Says Gaurav Agarwal Resigns As CFO

Reuters • 7 months ago

Vasa Denticity Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Marketscreener • 1 year ago

Vasa Denticity acquires 51% stake in IDS Denmed to create largest integrated dental supply network - The Economic Times

Economic Times • 1 year ago

Dental distribution company IDS Denmed gets nearly $30 mn tag in strategic deal

VCCircle • 1 year ago

Vasa Denticity consolidated net profit declines 33.70% in the March 2025 quarter | Capital Market News - Business Standard

Business Standard • 1 year ago

Dentalkart secures ₹85 crore funding to scale operations and expand subsidiaries

Expresshealthcare • 1 year ago

Dental marketplace Dentalkart scoops Rs 85 Cr funding from foreign institutional investors

Yourstory • 1 year ago

Vasa Denticity Limited Appoints Rohan Kaushikbhai Bhatt as Additional Director (Non-Executive)

Marketscreener • 1 year ago

Dentalkart Appoints Gaurav Agarwal as New Chief Financial Officer

Marketscreener • 2 years ago

Premium access

Complete news archive for InstaDent

Full article history, source details, and older brand coverage require an active premium plan.

Full article archive
Source and publication date
Older coverage
Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about InstaDent

When was InstaDent founded?

InstaDent was founded in 2021.

Where is InstaDent located?

InstaDent is headquartered in New Delhi, India. It is registered at New Delhi, Delhi, India.

How many employees does InstaDent have?

InstaDent has 94 employees.

What is the annual revenue of InstaDent?

The primary company behind InstaDent, Vasa Denticity Limited, reported revenue of ₹251 Cr for FY 2025, up 45% year on year.

What does InstaDent do?

InstaDent provides an online procurement platform for dental supplies and equipment through providing healthcare solutions, medical supplies, dental products, and online procurement. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of InstaDent?

InstaDent's top competitors include DentalKart, Prevest DenPro and CureMint.

Is InstaDent publicly traded?

Yes, InstaDent is publicly traded on NSE under the ticker symbol DENTALKART.

Which legal entities are associated with InstaDent?

InstaDent operates through Vasa Denticity Limited.

Who are the directors of InstaDent?

The legal entities of InstaDent currently have 7 directors, including Sandeep Aggarwal, Vikas Agarwal, Ravi Jagetiya and others.